Search for: "Robert C. Weill" Results 1 - 15 of 15
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Nov 2010, 8:26 am by Frank Pasquale
As Robert Kuttner of The American Prospect reports, “Fitch Ratings gives Bank of America and Citigroup ’stand alone’ ratings of C/D when external government support is not included but actual ratings of A-plus when it is. [read post]
26 Nov 2010, 8:27 am by Frank Pasquale
As Robert Kuttner of The American Prospect reports, "Fitch Ratings gives Bank of America and Citigroup 'stand alone' ratings of C/D when external government support is not included but actual ratings of A-plus when it is. [read post]
25 Sep 2008, 6:07 pm
(Johns Hopkins University)Siegel Ron (Northwestern University)Smith David C. [read post]
5 Jul 2023, 12:01 pm by admin
Many journalists struggle with reporting the results from risk factor epidemiology. [read post]
4 Dec 2023, 3:06 pm by Aaron Moss
Oh Mickey, you’re so fine—but you’re not alone: An avalanche of copyrighted works will enter the public domain in the United States on January 1, 2024. [read post]
27 Apr 2017, 1:30 am by Thaddeus Mason Pope, JD, PhD
Michelle Meyer, Geisinger Health System, (Still) Waiting to Exhale: Why the Future of Biospecimens Research Remains Unclear after the Final RuleMark Rothstein, University of Louisville School of Medicine, International Health ResearchNicolas Terry, Indiana University Robert H. [read post]
5 Jul 2011, 2:59 am
What are the lessons learned so far from the O104:H4 outbreak? [read post]
12 Dec 2021, 2:22 pm by admin
In assessing an association for causality, the starting point is “an association between two variables, perfectly clear-cut and beyond what we would care to attribute to the play of chance. [read post]
18 Jan 2022, 9:05 am by Katherine Pompilio
The committee will hear testimony from Willy C. [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]